Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Tirzepatide in Young Adults With Prader-Willi Syndrome, Hypothalamic Obesity and General Non-Syndromic Obesity

NCT06901245 is registered in ClinicalTrials.gov with Grace Kim as lead sponsor.

NCT NCT06901245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06901245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Tirzepatide in Young Adults With Prader-Willi Syndrome, Hypothalamic Obesity and General Non-Syndromic Obesity
Lead sponsor
Grace Kim
Phase
Phase 4
Overall status
Recruiting
Start date
May 1, 2025
Completion date
December 31, 2026
Enrollment
36 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hypothalamic obesity, obesity/therapy, prader-willi syndrome